Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Valneva Se ADR (NQ: VALN )

8.660 +0.100 (+1.17%)
Streaming Delayed Price Updated: 9:31 AM EDT, Jun 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Valneva Se ADR

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET Friday, 183 stocks hit new 52-week highs. Areas of Significance: Alphabet (NASDAQ:GOOG) was the biggest firm by market cap to hit a new 52-week... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Regencell Bioscience (NASDAQ:RGC) stock increased by 25.49% to $19.2 during Wednesday's pre-market session. The company's market cap stands at $242.7... 
Via Benzinga
Stocks That Hit 52-Week Highs On Tuesday
During Tuesday's morning session, 95 companies made new 52-week highs. Interesting Points: Alphabet (NASDAQ:GOOG) was the largest firm by market cap to set a... 
Via Benzinga
Valneva Initiates Rolling Submission For COVID19 Vaccine Candidate In UK
Valneva SE (NASDAQ: VALN) has commenced rolling submission for its COVID-19 vaccine candidate with the Medicines and Healthcare products Regulatory Agency (MHRA)... 
Via Benzinga
Exposures COVID-19
Valneva (VALN) Q2 2021 Earnings Call Transcript
VALN earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Valneva's Chikungunya Vaccine Candidate Shows Protective Neutralizing Antibodies In Late-Stage Trial
Valneva SE (NASDAQ: VALN) has announced positive topline results from the Phase 3 trial evaluating its single-shot chikungunya vaccine candidate in around 4,100... 
Via Benzinga
Valneva's Chikungunya Vaccine Candidate Gets FDA Breakthrough Tag
The FDA grants Breakthrough Therapy Designation to Valneva SE's (NASDAQ: VALN) single-shot chikungunya vaccine candidate, VLA1553. This new U.S. milestone... 
Via Benzinga
Exposures Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2021
Upgrades For Equity Residential (NYSE:EQR), BMO Capital upgraded the previous rating of Market Perform to Outperform. Equity Residential earned $0.68 in the first quarter... 
Via Benzinga
The Daily Biotech Pulse: Biohaven, Bristol-Myers Squibb Snag FDA Approvals, Iterum UTI Drug Review On Track, Centessa Pharmaceuticals Debuts On Nasdaq
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 27) BioCryst Pharmaceuticals,... 
Via Benzinga
Exposures Product Safety
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-... 
Via Benzinga
Exposures Product Safety
Earnings Scheduled For May 20, 2021
Companies Reporting Before The Bell • Meten EdtechX Education (NASDAQ:METX) is expected to report earnings for its first quarter. • Golar LNG (NASDAQ:GLNG) is... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.